Literature DB >> 23993762

Health economic evaluation of an infection prevention and control program: are quality and patient safety programs worth the investment?

Stefanie Raschka1, Linda Dempster, Elizabeth Bryce.   

Abstract

BACKGROUND: The effect of regional consolidation of an infection prevention and control (IPC) program on reduction of selected health care-acquired infections (HAIs), the economic burden of these illnesses, and where the potential for greatest financial benefit in reducing infection rates lies was assessed.
METHODS: Cost-benefit analysis (in Canadian $) was used to evaluate the effectiveness of a regional IPC program in preventing incident cases of HAIs. The costs of managing these infections, as well as the operational costs of the IPC program were compared against reductions in HAI rates over a 4-year period. Benefits were calculated as cost avoided by reducing HAI cases year over year.
RESULTS: The Health Authority spent more than $66.3 million managing 24,937 HAI cases over the 4-year evaluation period. Urinary tract infections, methicillin-resistant Staphylococcus aureus, and bacteremias incurred the greatest costs. A reduction of 4,739 HAI cases led to avoided costs of $9.1 million in 4 years; the IPC program budget was $6.7 million during this period.
CONCLUSION: Regionalization of the IPC program with standardized policies, procedures, and initiatives led to a 19% reduction in selected HAIs over 4 years and a cost avoidance of at least $9 million. This was particularly evident in years 3 and 4 of the program when $7.2 million (79% of the total) savings were realized.
Copyright © 2013 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Cost avoidance; Cost-benefit analysis; Surveillance

Mesh:

Year:  2013        PMID: 23993762     DOI: 10.1016/j.ajic.2012.10.026

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

1.  Evaluation of Nosocomial Infection Control Programs in health services.

Authors:  Mayra Gonçalves Menegueti; Silvia Rita Marin da Silva Canini; Fernando Bellissimo-Rodrigues; Ana Maria Laus
Journal:  Rev Lat Am Enfermagem       Date:  2015 Jan-Feb

Review 2.  Microorganisms in Confined Habitats: Microbial Monitoring and Control of Intensive Care Units, Operating Rooms, Cleanrooms and the International Space Station.

Authors:  Maximilian Mora; Alexander Mahnert; Kaisa Koskinen; Manuela R Pausan; Lisa Oberauner-Wappis; Robert Krause; Alexandra K Perras; Gregor Gorkiewicz; Gabriele Berg; Christine Moissl-Eichinger
Journal:  Front Microbiol       Date:  2016-10-13       Impact factor: 5.640

Review 3.  Economic evaluations and their use in infection prevention and control: a narrative review.

Authors:  Elissa Rennert-May; John Conly; Jenine Leal; Stephanie Smith; Braden Manns
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-27       Impact factor: 4.887

4.  Development and validation of a time and motion guide to assess the costs of prevention and control interventions for nosocomial infections: A Delphi method among experts.

Authors:  Eric Tchouaket Nguemeleu; Sandra Boivin; Stephanie Robins; Drissa Sia; Kelley Kilpatrick; Sylvain Brousseau; Bruno Dubreuil; Catherine Larouche; Natasha Parisien
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

5.  Estimating the cost of interventions to improve water, sanitation and hygiene in healthcare facilities across India.

Authors:  Katie K Tseng; Jyoti Joshi; Susmita Shrivastava; Eili Klein
Journal:  BMJ Glob Health       Date:  2020-12

Review 6.  Economic Evaluation of Interventions for Prevention of Hospital Acquired Infections: A Systematic Review.

Authors:  Habibollah Arefian; Monique Vogel; Anja Kwetkat; Michael Hartmann
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.